ESS
62
-3
IBM
47
-3
COF
62
3
ALLE
37
-4
RIG
43
-7
FITB
60
-5
CRM
60
-7
FFIV
66
-4
MCD
52
-5
KIM
72
2
MS
77
-2
CMA
61
-3
URI
60
-6
MCO
71
-7
TEL
60
-8
ROST
57
-3
EFX
30
-8
JNJ
41
3
NOV
52
-5
DAL
84
-3
ESS
62
-3
IBM
47
-3
COF
62
3
ALLE
37
-4
RIG
43
-7
FITB
60
-5
CRM
60
-7
FFIV
66
-4
MCD
52
-5
KIM
72
2
MS
77
-2
CMA
61
-3
URI
60
-6
MCO
71
-7
TEL
60
-8
ROST
57
-3
EFX
30
-8
JNJ
41
3
NOV
52
-5
DAL
84
-3
Financhill
Back

Global X NASDAQ 100 Covered Call ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
54

QYLD
Global X NASDAQ 100 Covered Call ETF

Last Price:
18.07
Seasonality Move:
-0.58%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
54
Global X NASDAQ 100 Covered Call ETF (QYLD) is a Buy

Is Global X NASDAQ 100 Covered Call ETF a Buy, Sell or Hold?

  • The current Global X NASDAQ 100 Covered Call ETF [QYLD] share price is $18.08. The Score for QYLD is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • QYLD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QYLD Stock Price Chart

What is Global X NASDAQ 100 Covered Call ETF's stock price today?

  • The Global X NASDAQ 100 Covered Call ETF share price today is $18.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QYLD is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

QYLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 42.69 Sell
Chaikin Money Flow: -6118472 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.08 - 18.44) Sell
Bollinger Bands (100): (17.42 - 18.28) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

QYLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.47 Sell
20-day SMA: 18.27 Sell
50-day SMA: 18.12 Sell
200-day SMA: 17.79 Buy
8-day EMA: 18.38 Sell
20-day EMA: 18.3 Sell
50-day EMA: 18.13 Sell
200-day EMA: 17.79 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Global X NASDAQ 100 Covered Call ETF Earnings Growth & QYLD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Global X NASDAQ 100 Covered Call ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):